Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anita Deswal

Showing results (1-10 of 235) with videos related to

Pageof 24
Sort By:
Current Cardiology Reports|May 4, 2005
Diastolic dysfunction and diastolic heart failure: mechanisms and epidemiologyAnita Deswal
Transactions of the American Clinical and Climatological Association|August 7, 2025
THE OBESITY PARADOX IN HEART FAILURE: TIME TO MOVE FORWARDAnita Deswal
Annals of Internal Medicine|May 31, 2021
In older patients with permanent AF and HF, digoxin and bisoprolol did not differ for QoL at 6 moKaveh Karimzad, Anita Deswal
Current Treatment Options in Cardiovascular Medicine|November 26, 2008
Treatment of patients with heart failure and preserved ejection fractionAnita Deswal, Biykem Bozkurt
Cardiology Clinics|March 4, 2008
Role and optimal dosing of angiotensin-converting enzyme inhibitors in heart failureDhruv Kazi, Anita Deswal
Annals of Internal Medicine|March 4, 2024
In adults with overweight or obesity and CVD, but without diabetes, semaglutide reduced MACE at a mean 40 moEfstratios Koutroumpakis, Anita Deswal
Heart Failure Clinics|September 30, 2018
Aldosterone Receptor Blockade in Heart Failure with Preserved Ejection FractionAjith Nair, Anita Deswal
The American Journal of Cardiology|April 18, 2006
Comparison of morbidity in women versus men with heart failure and preserved ejection fractionAnita Deswal, Biykem Bozkurt
Annals of Internal Medicine|January 6, 2026
In HFrEF, adding digitoxin to standard care reduced a composite of death or first worsening HF hospitalization at a median 36 moSalil Kumar, Anita Deswal,
Current Treatment Options in Cardiovascular Medicine|June 24, 2004
Aldosterone Receptor Blockers in the Treatment of Heart FailureAnita Deswal, David Yao
Pageof 24

Showing results (1-10 of 235) with videos related to

Sort By:
Pageof 24
Current Cardiology Reports|May 4, 2005
Diastolic dysfunction and diastolic heart failure: mechanisms and epidemiologyAnita Deswal
Transactions of the American Clinical and Climatological Association|August 7, 2025
THE OBESITY PARADOX IN HEART FAILURE: TIME TO MOVE FORWARDAnita Deswal
Annals of Internal Medicine|May 31, 2021
In older patients with permanent AF and HF, digoxin and bisoprolol did not differ for QoL at 6 moKaveh Karimzad, Anita Deswal
Current Treatment Options in Cardiovascular Medicine|November 26, 2008
Treatment of patients with heart failure and preserved ejection fractionAnita Deswal, Biykem Bozkurt
Cardiology Clinics|March 4, 2008
Role and optimal dosing of angiotensin-converting enzyme inhibitors in heart failureDhruv Kazi, Anita Deswal
Annals of Internal Medicine|March 4, 2024
In adults with overweight or obesity and CVD, but without diabetes, semaglutide reduced MACE at a mean 40 moEfstratios Koutroumpakis, Anita Deswal
Heart Failure Clinics|September 30, 2018
Aldosterone Receptor Blockade in Heart Failure with Preserved Ejection FractionAjith Nair, Anita Deswal
The American Journal of Cardiology|April 18, 2006
Comparison of morbidity in women versus men with heart failure and preserved ejection fractionAnita Deswal, Biykem Bozkurt
Annals of Internal Medicine|January 6, 2026
In HFrEF, adding digitoxin to standard care reduced a composite of death or first worsening HF hospitalization at a median 36 moSalil Kumar, Anita Deswal,
Current Treatment Options in Cardiovascular Medicine|June 24, 2004
Aldosterone Receptor Blockers in the Treatment of Heart FailureAnita Deswal, David Yao
Pageof 24